S urgical planning and risk assessment are an important part of the presurgical patient evaluation. Numerous comorbidities have been cited as risk factors for poor outcomes after surgery. [1] [2] [3] [4] Many of these comorbid conditions are inadequate measures of overall physical functioning. 2, 5, 6 Scoring systems such as the Charlson comorbidity index have been developed to assist with risk stratification for perioperative morbidity. [7] [8] [9] Classically, these systems rely only on the presence or absence of comorbid conditions. These conditions, while strong surrogates, do not correlate entirely with physiologic reserve required for recovery from surgery. 10, 11 Sarcopenia is defined as the loss of skeletal muscle mass that occurs as part of the aging process. 12, 13 This has been shown to be accelerated in patients with chronic medical conditions and in the malnourished. [14] [15] [16] [17] It is an insidious finding that may be missed on subjective examination alone. Sarcopenia is a predictor of postoperative morbidity in a variety of surgical populations including procedures for malignancy and organ transplantation. 15, 18, 19 Crohn's disease (CD) and ulcerative colitis (UC) are complex diseases characterized by malnutrition, frequent relapses, and an increased risk for surgical intervention due to medically refractory disease. 20 The role of sarcopenia in the evolution of inflammatory bowel disease (IBD) remains undefined. Furthermore, the impact of sarcopenia on surgical outcomes in IBD has not been evaluated. This retrospective cohort study seeks to better define the role that sarcopenia plays in the perioperative outcomes of a population of individuals with IBD undergoing major abdominal operations. It is the hypothesis of this study that there is a sarcopenia associated with IBD which is distinct from that which is seen with aging and that this will predict increased postoperative morbidity.
METHODS

Patients and Sarcopenia Quantification
A retrospective study of patient charts and the American College of Surgeons National Surgical Quality Improvement Program database of those patients with IBD who underwent major abdominal surgeries exclusive of diversions or ostomy reversals at the University of Iowa Hospitals and Clinics (UIHC) between 2010 and 2015 was completed. Before undertaking this review, appropriate approval from the UIHC Institutional Review Board (IRB) was obtained. A waiver of informed consent was obtained because of the retrospective nature of this research. Records were reviewed for a 90-day window on either side of the operation and inclusive of the preoperative clinical assessment data and postoperative complications. Complications were graded using the Clavien-Dindo classification scheme. 21 CT measurements were recorded on studies completed within 90 days preoperatively and 10 days postoperatively (Fig. 1) . Sarcopenia quantification was completed by the senior author using the validated method described by Joglekar et al. 19 Sarcopenia was defined as Total Psoas Index (TPI) or mean Hounsfield unit average calculations (HUAC) within the lowest sex quartile at the level of the third lumbar vertebral body with the most complete bony structure creating the vertebral foramen. Given the unremitting nature of IBD, it was important to verify that this study population was not more likely to have decreased TPI or mean HUAC when compared with the general population. This was assessed using a cohort of patients admitted for trauma alerts from 2012 to 2015 as a control group representative of society as a whole. The mean TPI and HUAC between the 2 groups was compared to evaluate for significant intergroup disparities.
Statistical Analysis
Univariate logistic regression was used to determine which perioperative variables were significantly associated with operative complications. Variables abstracted as potential predictors included the following: age, body mass index, UC diagnosis, CD diagnosis, use of IBD-modifying medications in the preoperative setting, hypertension, dyslipidemia, diabetes mellitus, congestive heart failure, coronary artery disease or history of myocardial infarction, stroke, peripheral vascular disease, chronic obstructive pulmonary disease, asthma, chronic liver disease, chronic kidney disease, smoking status, history of venous thrombosis, abdominal wall fat, hip girdle fat, visceral fat, complete blood count (CBC) values, blood urea nitrogen, liver function tests, albumin and prealbumin, and international normalized ratio (INR). Complications abstracted from records were Time in ICU, length of stay, readmission, need for transfusion, skin and soft tissue infections, organ space infection, wound dehiscence, central line-associated blood stream infections (CLABSI), catheter-related urinary tract infections (UTI), pneumonia, postoperative sepsis, reoperation, venous thrombosis requiring treatment, death within 30 days, and death within 90 days. Multivariable logistic regression models were constructed for all age groups in question using predictor variables found to be significantly associated with complications. Given the study hypothesis, a receiver operator characteristic (ROC) analysis for all complications recorded was used to identify appropriate age cutoff for analysis. The predictive capacity of mean HUAC was assessed for its ability to predict all complications for the study at age cutoffs of 35, 40, and 45. Finally, differences in TPI and mean HUAC between patients with IBD and trauma control patients were compared using student's t test. The analysis of the control population was limited to assessing for the presence of ubiquitous sarcopenia in the IBD cohort. The remainders of the evaluations on the effects of sarcopenia on surgical outcomes were restricted to the IBD population only.
RESULTS
There were 178 patients with IBD enrolled. A total of 855 trauma patients were used only to assess for the pervasiveness of sarcopenia in the IBD cohort. The average age of the study population was 42.7. Fifty-one patients (29%) were diagnosed with UC and 127 (71%) with CD. Eighty-three percent of the population was on at least 1 medication for their IBD, including 48.6% on steroids and 23.7% on immunomodulators ( Table 1) . The most common surgery was an open partial colectomy (39.3%). Forty-four (24.72%) patients met the criteria for sarcopenia. The mean age of the patients who met criteria for sarcopenia (56.8) was significantly increased from those who did not (40.5) (P , 0.0001). This group was also more likely to have hypertension (odds ratio ¼ 2.23) and be diabetic (odds ratio ¼ 5.27) ( Table 2 ). The TPI and mean HUAC from the trauma and IBD populations were not significantly different (P ¼ 0.126).
The average length of stay was 8 days, with 13 patients requiring ICU admission. Twenty-nine patients required a blood transfusion postoperatively. Sepsis was diagnosed in 20 patients and 64 required readmission within 90 days of discharge. There Immunomodulators included azathioprine, methotrexate, and 6-mercaptopurine. Biologics used included adalimumab, infliximab, and certolizumab pegol.
was 1 mortality within 90 days of discharge and 8 patients required reoperation. There were 123 total complications reported (69%) ( Table 3 ). There were 14 complications included in univariate analysis with multiple preoperative variables significantly associated with complications. Sarcopenia as defined by HUAC and TPI was significantly associated with receiving a blood transfusion. Sarcopenia defined by mean HUAC was significantly associated with organ space infections, postoperative sepsis, increased length of stay, deep vein thrombosis, and admission to the ICU in univariate analysis (Table 4) . TPI was not associated with variables other than receipt of a blood transfusion. When considering the entire study group, there was no association between Clavien-Dindo complication grades and the presence of sarcopenia. There was no correlation between the use of different categories of medications (steroids, immunomodulators, or biologics) and complications in this population. Furthermore, no laboratory values used as surrogates for nutritional health including albumin and prealbumin were predictive of perioperative morbidity. ROC analysis showed that HUAC had the greatest predictive capacity for complications at the age cutoff of 40 (ROC area ¼ 0.789) (Fig. 2) . When multivariable analysis is performed in patients younger than 40 years, both HUAC and TPI were significantly associated with the need for blood transfusions.
However, only HUAC was significantly correlated with ICU admission and postoperative sepsis. HUAC was also the only operational definition of sarcopenia that was an independent predictor of a patient developing deep vein thrombosis that required treatment. It was also associated with Clavien-Dindo complication grade 4 or higher (Table 5) . Surgery type was included in the analysis but was not an independent predictor of risk in the final multivariable analysis. Furthermore, there were only 4 nonelective operations, and these data did not influence the overall outcomes.
DISCUSSION
Sarcopenia is an occult process characterized by the loss of muscle mass in a patient. 22 Age-related sarcopenia is ubiquitous, occurring in the preponderance of individuals as a part of the aging process. This sarcopenia is distinct from that which is related to factors such as malnutrition and chronic illness. It is this involuntary loss of muscle mass which has been associated with an increased risk of disability. 23 Its significance in a surgical population lies in its effect on the physiologic reserve of patients and their ability to recover from an operation. 10, 11, 15, 18, 19 In a study by Joglekar et al, the role of sarcopenia in surgical outcomes in a cohort of patients who underwent pancreaticoduodenectomy for malignancy was assessed. 19 This article showed patients with sarcopenia to be at risk for similar postoperative complications noted in this study, including infections, ICU admission, and high-grade complications. It has also been associated with increased length of stay and perioperative mortality in colorectal surgery, shorter recurrence-free survival in endometrial cancer, and mortality in liver transplant patients. 15, 22, 24, 25 With the increasing emphasis on improving outcomes and the clear association between sarcopenia and perioperative morbidity, defining the presence of sarcopenia will likely become increasingly important.
UC and CD are chronic illnesses characterized by their relapsing nature and poor nutritional status. Notwithstanding significant advancements in medical management, upward of 15% of patients with UC and 80% of patients with CD eventually require surgical intervention. 26, 27 Despite the increasing emphasis placed on the use of immunomodulators, progression to surgery has not decreased. 28 The impact of sarcopenia on surgical outcomes for patients with IBD has not been defined. Given this ambiguity, a retrospective review of patients with IBD who underwent abdominal surgery at a major academic medical center was conducted.
Because of the chronicity of IBD and the potential for pervasive sarcopenia, this cohort was compared with the control group of 855 consecutive patients presenting as a trauma alert. Based on this comparison, this population with IBD was not more likely to suffer from sarcopenia (P ¼ 0.126). This is significant in that it demonstrates that an IBD population is not inherently different in its constitution than the general populace. On univariate analysis, sarcopenia was significantly associated with the necessity for blood transfusion, organ space infections, postoperative sepsis, increased length of stay, admission to the ICU, and development of a deep vein thrombosis (Table 5 ). Interestingly, it was not associated with any Clavien-Dindo grade complications on univariate analysis. Furthermore, serum albumin and prealbumin, parameters considered to be indicators of malnutrition, were also not significantly associated with individual or Clavien-Dindo grade complications. Perhaps most surprising, there was no association between perioperative morbidity and the use IBD treatments, including the use of steroids, biologics, and immunomodulators.
The average age of patients who met the criteria for sarcopenia was significantly older than those who did not (56.8 versus 40.5, P , 0.0001). This is consistent with what is known about the deterioration of skeletal muscle mass with aging. [12] [13] [14] 29 With that said, previous studies have identified sarcopenia as a more important risk factor for perioperative morbidity than chronologic age. Englesbe defined the concept of morphometric age, identifying it as an independent risk factor for postoperative mortality and increased length of stay. This calculated "age" has been shown to more accurately reflect the risk for complications than chronologic age. 14, 30 The outcomes of this investigation are consistent with this concept and its importance in a patient's fitness. When using ROC analysis, an age of 40 was identified as the best cutoff for analysis (Fig. 2) . In this group, sarcopenia was a significant risk factor for postoperative complications in multivariate analysis. Conversely, this was not noted in those patients older than 40 years. It is hypothesized that age-related sarcopenia is not a pathologic process and does not adversely influence a patient's ability to tolerate the insult accompanying a surgery. Conversely, the sarcopenia of chronic disease noted in a younger population is correlated with a deleterious effect on patient fitness and increased morbidity. In this group, this disability presented as a significant increase in risk for transfusion, postoperative sepsis, necessity of ICU admission, venous thrombosis requiring treatment, and Clavien-Dindo complication grade 4 or higher. Sarcopenia is an occult process which does not correlate well with outward appearance. Populations who are labeled sarcopenic can have mean body mass indices that are bordering on obese. 22 Ormsbee et al identified a cohort with increased body weight, but without a concomitant increase in skeletal muscle mass or bone mineral density. This group, which they identified as having osteosarcopenic obesity, was at an increased risk for falls, impaired overall functioning, increased chemotherapy toxicity, and decreased overall survival in cancer. 31 In this current study, patients younger than 40 years who were sarcopenic had body mass indices that were significantly more likely to be normal or elevated (P ¼ 0.001). This was also true when considering the population as a whole. The importance of recognizing the occult process of skeletal muscle loss in evaluating surgical patients cannot be understated. In the absence of diagnostic imaging or targeted measurement of lean mass, sarcopenia would otherwise go unnoticed. Sarcopenia is directly associated with increased morbidity and mortality in multiple studies. This has similarly been demonstrated in this cohort with IBD. A targeted assessment for sarcopenia would necessarily identify an at-risk population and provide for an opportunity to intervene and improve perioperative outcomes.
There are several weaknesses of this study. The first is that it is a single-center study of patients with IBD with a limited number of subjects. Furthermore, surgery is considered for refractory disease, when the adverse side effects of medications warrant surgery, or a surgical complication (i.e., stricture, fistula, perforation, or dysplasia/neoplasm). The role of sarcopenia in leading up to surgery is not well defined and not answered by this study. With that said, this was a study about the impact of sarcopenia on surgical outcomes. Future directions of the study would include a prospective assessment of the role of sarcopenia and the progression to surgery across multiple centers. In addition, studies investigating the implementation of a preoperative program of nutritional rehabilitation and physical therapy would elucidate the reversibility of this state and its influence on postoperative morbidity.
CONCLUSION
Sarcopenia is a significant risk factor for increased morbidity in many different pathologies. This investigation demonstrates that sarcopenia is a risk factor for poor surgical outcomes among young patients who undergo abdominal surgery at a major academic medical center. Perhaps more importantly, sarcopenia is an insidious finding which is not often recognized on physical examination. Diagnostic imaging may be required to obtain an accurate description of a patient's physiologic reserve. This assessment is important, as it can result in better preoperative planning and more accurate information for counseling patients on the risks of surgery. In addition, it affords the surgeon an opportunity to identify a group that would benefit from nutritional status optimization before surgery.
